Latest news:          EntreChem participates in the ERA-Co-Biotech project MISSION…          [ read more ]

News & Press Releases [ subscribe for updates ]

Media (spanish)

EntreChem participates in the ERA-Co-Biotech project "MISSION - Streamlined Streptomyces cell factories for industrial production of valuable natural products."

EntreChem, 2 European Universities and Novartis to cooperate in the project

May 30th, 2018 - Oviedo (Spain)

The project belongs to the ERA-Net Cofund on Biotechnologies (under the Framework Programme Horizon 2020)…

EC-70124 acts as dual FLT3 PIM inhibitor
and exerts potent activity in acute myeloid leukemia

January 17th, 2018 - Oviedo (Spain)

The research, focuses on preclinical models bearing FLT3 mutations, and its blocking by EC-70124, a multi-kinase inhibitor previously characterized in solid tumor models…

New Oncotarget publication: EntreChem's mithralog EC-8042 targets sarcoma cancer stem cells by inhibiting SP1 transcription factor

May 2nd, 2016 - Oviedo (Spain)

The results of a collaborative research from EntreChem SL and the Hospital Universitario Central de Asturias, HUCA (Oviedo, Spain), focused on a new strategy for treating sarcomas, especially targeting the tumor initiating cells…

more news & media

La biotecnología tira del carro investigador

07-10-2013, La Nueva España

La molécula EC-70124 de EntreChem muestra actividad por vía oral en cáncer de próstata

20-05-2013, El Comercio

Los grupos Alimerka y Orejas refuerzan sus posiciones en el laboratorio Entrechem

22-06-2012, La Nueva España

Antitumorales ‘made in’ Asturias

07-07-2011, El País

Tras la química combinatoria, análogos al poder

21-06-2011, Diario Médico

EntreChem necesita 5 millones para curar el tumor cerebral

31-05-2011, Expansión